Quarterly report [Sections 13 or 15(d)]

Common Stock Warrants and Options (Details Narrative)

v3.26.1
Common Stock Warrants and Options (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Apr. 30, 2022
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
May 31, 2025
Feb. 26, 2025
Options outstanding intrinsic value vested and exercisable   $ 133,730        
Vesting warrants           21,145
Exercise price per share           $ 2.8375
Warrants rights outstanding           5 years
Common stock awards granted          
Stock option outstanding   597,550   597,550    
Rstricted stock granted   25,935        
Granted, shares   126,515        
Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term   9 years 1 month 6 days        
Options outstanding intrinsic value   $ 0        
Fair value of vested stock options   $ 46,000 $ 3,000      
Stock option, exercisable   475,328        
Stock option, unvested compensation   $ 143,000        
2022 Omnibus Incentive Plan [Member]            
Common stock awards granted 583,334          
2022 Omnibus Incentive Plan [Member] | Maximum [Member]            
Common stock awards granted 750,000          
Greenshoe Rights [Member]            
Conversion price , Shares         0.454  
Common Warrants [Member]            
Exercise price per share   $ 0.454        
Class of warrant or right outstanding   50,737,682        
Securities Purchase Agreement [Member] | Vesting Warrants [Member]            
Warrants rights outstanding         5 years  
Securities Purchase Agreement [Member] | Series L 10% Convertible Preferred Stock [Member] | Common Warrants [Member]            
Vesting warrants         3,235,978  
Exercise price per share         $ 2.043  
Securities Purchase Agreement [Member] | Series L 10% Convertible Preferred Stock [Member] | Vesting Warrants [Member]            
Vesting warrants         11,756,406  
Exercise price per share         $ 2.043